NSPR
InspireMD Inc
0.751$
-1.0%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -49.6% | +62.9% | -35.1% | +101.2% | -19.6% | +79.9% | +123.4% | -37.9% | +93.3% | -1.8% | +48.3% | |
| – | -50.6% | +85.5% | -40.0% | +121.5% | -31.6% | +96.4% | +141.8% | -42.5% | +107.1% | -8.2% | +51.7% | |
| – | -48.3% | +130.8% | -50.6% | +152.9% | -41.2% | +129.3% | -5.1% | -61.4% | +108.1% | +96.2% | -52.7% | |
| – | -48.3% | +130.8% | -50.6% | +152.9% | -41.2% | +129.3% | +169.2% | -47.7% | +119.2% | -11.2% | +56.5% | |
| – | -45.0% | -6.2% | +65.7% | -3.5% | +18.7% | -2.9% | +47.0% | -10.2% | +44.7% | +24.9% | +13.9% | |
| – | -60.9% | -33.6% | +6.6% | +112.8% | +9.0% | +14.5% | -19.2% | +41.8% | +29.9% | +22.0% | +32.1% | |
| – | -24.1% | -19.7% | +25.6% | -11.6% | +29.9% | -18.1% | +282.4% | +44.2% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -38.8% | -38.5% | -37.0% | +4.3% | +27.6% | +24.8% | +10.1% | +17.5% | +12.1% | +31.7% | +32.5% | |
| – | -18.3% | -30.9% | -48.1% | +17.6% | +6.7% | +18.9% | +17.3% | +16.6% | +18.7% | +27.5% | +39.5% | |
| – | +8.9% | -35.4% | -100.0% | – | – | +10.5% | +5.0% | -0.2% | +32.9% | -2.7% | +96.7% | |
| – | -43.7% | +20.7% | -46.9% | +183.2% | -30.5% | -63.5% | +278.4% | -26.2% | +42.5% | +33.5% | +0.1% | |
| – | -78.4% | -100.0% | – | – | – | – | – | – | – | – | – | |
| – | – | – | -32.6% | +221.3% | -38.6% | +126.0% | +175.7% | -48.1% | +127.1% | -8.6% | +53.0% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +83.3% | +409.1% | +3,432.1% | +1,455.6% | +352.8% | +985.5% | +385.7% | +7.2% | +208.3% | +72.8% | +75.2% |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.